Atossa Therapeutics Inc (NASDAQ:ATOS)
| 0.7673 Delayed Data As of 3:57pm ET |  -0.0606 / -7.32%Today’s Change | 0.50 Today|||52-Week Range 1.62 | +45.18% Year-to-Date |
Latest ATOS News | Press Releases
No recent news for Atossa Therapeutics Inc.
Today’s Trading
| Previous close | 0.83 |
| Today’s open | 0.81 |
| Day’s range | 0.76 - 0.81 |
| Volume | 7,531 |
| Average volume (3 months) | 531,947 |
| Market cap | $105.8M |
Data as of 3:57pm ET, 02/08/2023
Growth & Valuation
| Earnings growth (last year) | +91.08% |
| Earnings growth (this year) | -22.22% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.77 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ISRIsoray Inc | -0.01 | -3.57% |
| ---- | ||
| CDTXCidara Therapeutics ... | 0.00 | 0.00% |
| HEXOHexo Corp | -0.07 | -4.55% |
Data as of 3:58pm ET, 02/08/2023
Financials
| Next reporting date | March 30, 2023 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$20.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
